Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matrix-associated autologous chondrocyte transplantation for grade 4 knee cartilage lesions
2015-003584-11Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Sep 2015
- Modality
- Cell Therapies, Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of biomimetic cartilage matrix + autologous chondrocytes in chondral knee defect and Knee Osteochondral Defect (OCD), sponsored by Medical University of Innsbruck. Primary endpoints: Clinical outcome scores and Radiological outcome (MRI). Started Sep 2015; status: completed.
02
Drugs
biomimetic cartilage matrix + autologous chondrocytes
03
Conditions
chondral knee defectKnee Osteochondral Defect (OCD)
Beyond the preview
Go deeper on 2015-003584-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003584-11.